MHLW to Issue Development Requests for 8 Drugs/Indications Determined to Have Unmet Medical Needs by Council on Unapproved Drugs

The Ministry of Health, Labor and Welfare’s (MHLW) Council on Unapproved Drugs and Indications with Unmet Medical Needs (chairman: Tomomitsu Hotta, chief director, National Cancer Center) agreed at a meeting on July 30 that one unapproved drug, ibuprofen lysine (patent...read more